ReviewFuture oncology (London, England)2024

An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancer.

Ates Kutay Tenekeci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.